The largest database of trusted experimental protocols

Mir 133b inhibitor

Manufactured by RiboBio
Sourced in China

The MiR-133b inhibitor is a laboratory reagent used in research applications. It functions to inhibit the expression or activity of the microRNA miR-133b. miR-133b is involved in various cellular processes and its regulation can be studied using this inhibitor. The core function of this product is to provide researchers with a tool to modulate miR-133b levels in experimental settings.

Automatically generated - may contain errors

2 protocols using mir 133b inhibitor

1

Transfection of Endometrial Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RL95 to 2 (No.TCHu198), Ishikawa, HEC-1-A(No.TCHu149) and HEC-1-B(No.TCHu115) EC cell lines were purchased from Shanghai Chinese Academy of Sciences Cell Bank and were cultured in DMEM, containing 10% FBS (Gibco; Thermo Fisher Scientific, Inc.;Cat:10099141C) and 1% penicillin/streptomycin (Gibco; Thermo Fisher Scientific, Inc.; Cat: 15140148) at 37 °C in a humidified incubator with 5% CO2. The RL95 to 2 and HEC-1-A cell lines were transfected with negative control (NC) mimic, miR-133b mimic, NC inhibitor or miR-133b inhibitor (all cell lines were purchased from Guangzhou RiboBio Co., Ltd). Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.; Cat: 11668019), was used for transfection, according to the manufacturer's instructions and subsequent experimentation was performed 48 h following.
+ Open protocol
+ Expand
2

IGF-1 Effects on Isolated MI Oocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The isolated MI oocytes were cultured at 37°C and 5% CO2 in G-2 PLUS (Vitrolife, Frölunda, Sweden) treated with (45 oocytes) or without (62 oocytes) 200 ng/ml IGF-1 (Peprotech, Rocky Hill, NJ, USA) for 24 h, then covered with ovoil (Vitrolife). After 24 h, all oocytes were stored at 80°C until RNA was extracted. The average age of patients without IGF-1 treatment was 31.66±3.90. The average age of patients with IGF-1 treatment was 31.25±3.31. No apparent bias was detected between these two groups.
The 293T cells injected with MiR-133b mimic, MiR-133b mimic negative control, MiR-133b inhibitor, or MiR-133b inhibitor negative control (NC) (Ribobio, Guangzhou, China) were cultured at 37°C and 5% CO2 in DMEM (Gibco, Grand Island, USA) and supplemented with 10% fetal bovine serum and 1% antibiotics (100 U/ml penicillin and 100 U/ml streptomycin.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!